Asia (including Southeast Asia, China, and India) India – CDSCO/SEC pauses Bharat Biotech MTBVAC Phase III authorisation (6 June 2026) India’s Subject Expert Committee identified data gaps and a serious adverse...
Health Secretary Kennedy’s new policy direction on vaccines centers on undermining CDC assurances about vaccine safety (especially regarding autism and aluminum adjuvants) and on opening the door to schedule changes...
The landmark study by Reichert et al. (2001) systematically analyzed the impact of Japan’s national policy to vaccinate schoolchildren against influenza on overall and pneumonia/influenza-associated mortality, spanning...